Uncertainty during the transition from cancer patient to survivor

John P. Garofalo, Sheela Choppala, Heidi A. Hamann, Jill Gjerde

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

This prospective study evaluated the impact that uncertainty has on quality of life as cancer patients end the active phase of their treatment. The transition from patient status to survivor may be a particularly important point in recovery because it may affect how much stress cancer survivors experience. Guided by a within-subjects design framework, 53 cancer patients (predominantly breast cancer) participated in the present study as they approached the end of adjuvant treatment and were followed for 4 months. Distress levels increased the further patients moved away from the end-of-active treatment; however, preceding these ascending scores of distress was a period characterized by little unrest-best described as a "honeymoon" phase. Using hierarchical linear modeling, greater uncertainty 1 month after treatment ended predicted more functional and physical impairment 4 months after the completion of adjuvant treatment. In both cases, uncertainty accounted for nearly 70% of the variance of these changes over time. A period of rest may emerge as active treatment ends, but that it is short-lived, particularly if uncertainty regarding health emerges. Furthermore, uncertainty may a represent a key mechanism (and target for intervention) during the transition from cancer patient to survivor.

Original languageEnglish (US)
Pages (from-to)E8-E14
JournalCancer nursing
Volume32
Issue number4
DOIs
StatePublished - Jul 1 2009
Externally publishedYes

Fingerprint

Patient Transfer
Uncertainty
Survivors
Neoplasms
Therapeutics
Quality of Life
Prospective Studies
Breast Neoplasms
Health

Keywords

  • Cancer survivor
  • Emotional distress
  • Quality of life
  • Uncertainty

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

Uncertainty during the transition from cancer patient to survivor. / Garofalo, John P.; Choppala, Sheela; Hamann, Heidi A.; Gjerde, Jill.

In: Cancer nursing, Vol. 32, No. 4, 01.07.2009, p. E8-E14.

Research output: Contribution to journalArticle

Garofalo, John P. ; Choppala, Sheela ; Hamann, Heidi A. ; Gjerde, Jill. / Uncertainty during the transition from cancer patient to survivor. In: Cancer nursing. 2009 ; Vol. 32, No. 4. pp. E8-E14.
@article{af3c29652f334a3391fee765d08e50fd,
title = "Uncertainty during the transition from cancer patient to survivor",
abstract = "This prospective study evaluated the impact that uncertainty has on quality of life as cancer patients end the active phase of their treatment. The transition from patient status to survivor may be a particularly important point in recovery because it may affect how much stress cancer survivors experience. Guided by a within-subjects design framework, 53 cancer patients (predominantly breast cancer) participated in the present study as they approached the end of adjuvant treatment and were followed for 4 months. Distress levels increased the further patients moved away from the end-of-active treatment; however, preceding these ascending scores of distress was a period characterized by little unrest-best described as a {"}honeymoon{"} phase. Using hierarchical linear modeling, greater uncertainty 1 month after treatment ended predicted more functional and physical impairment 4 months after the completion of adjuvant treatment. In both cases, uncertainty accounted for nearly 70{\%} of the variance of these changes over time. A period of rest may emerge as active treatment ends, but that it is short-lived, particularly if uncertainty regarding health emerges. Furthermore, uncertainty may a represent a key mechanism (and target for intervention) during the transition from cancer patient to survivor.",
keywords = "Cancer survivor, Emotional distress, Quality of life, Uncertainty",
author = "Garofalo, {John P.} and Sheela Choppala and Hamann, {Heidi A.} and Jill Gjerde",
year = "2009",
month = "7",
day = "1",
doi = "10.1097/NCC.0b013e31819f1aab",
language = "English (US)",
volume = "32",
pages = "E8--E14",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Uncertainty during the transition from cancer patient to survivor

AU - Garofalo, John P.

AU - Choppala, Sheela

AU - Hamann, Heidi A.

AU - Gjerde, Jill

PY - 2009/7/1

Y1 - 2009/7/1

N2 - This prospective study evaluated the impact that uncertainty has on quality of life as cancer patients end the active phase of their treatment. The transition from patient status to survivor may be a particularly important point in recovery because it may affect how much stress cancer survivors experience. Guided by a within-subjects design framework, 53 cancer patients (predominantly breast cancer) participated in the present study as they approached the end of adjuvant treatment and were followed for 4 months. Distress levels increased the further patients moved away from the end-of-active treatment; however, preceding these ascending scores of distress was a period characterized by little unrest-best described as a "honeymoon" phase. Using hierarchical linear modeling, greater uncertainty 1 month after treatment ended predicted more functional and physical impairment 4 months after the completion of adjuvant treatment. In both cases, uncertainty accounted for nearly 70% of the variance of these changes over time. A period of rest may emerge as active treatment ends, but that it is short-lived, particularly if uncertainty regarding health emerges. Furthermore, uncertainty may a represent a key mechanism (and target for intervention) during the transition from cancer patient to survivor.

AB - This prospective study evaluated the impact that uncertainty has on quality of life as cancer patients end the active phase of their treatment. The transition from patient status to survivor may be a particularly important point in recovery because it may affect how much stress cancer survivors experience. Guided by a within-subjects design framework, 53 cancer patients (predominantly breast cancer) participated in the present study as they approached the end of adjuvant treatment and were followed for 4 months. Distress levels increased the further patients moved away from the end-of-active treatment; however, preceding these ascending scores of distress was a period characterized by little unrest-best described as a "honeymoon" phase. Using hierarchical linear modeling, greater uncertainty 1 month after treatment ended predicted more functional and physical impairment 4 months after the completion of adjuvant treatment. In both cases, uncertainty accounted for nearly 70% of the variance of these changes over time. A period of rest may emerge as active treatment ends, but that it is short-lived, particularly if uncertainty regarding health emerges. Furthermore, uncertainty may a represent a key mechanism (and target for intervention) during the transition from cancer patient to survivor.

KW - Cancer survivor

KW - Emotional distress

KW - Quality of life

KW - Uncertainty

UR - http://www.scopus.com/inward/record.url?scp=67651123147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651123147&partnerID=8YFLogxK

U2 - 10.1097/NCC.0b013e31819f1aab

DO - 10.1097/NCC.0b013e31819f1aab

M3 - Article

C2 - 19444082

AN - SCOPUS:67651123147

VL - 32

SP - E8-E14

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 4

ER -